Further investigation into the mechanisms by which SREBP1c regulates HSCs and liver fibrosis [51] demonstrated that overexpression of SREBP1c inhibited liver fibrosis in mice by reducing the levels of TGFβ1 and signaling via SMAD3 and Akt1/2/3 [59]. This evidence concerns the gene SMAD3 and Hepatic fibrosis.